Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ADC, aerial, Albert, Alexion, Androgen, angiogenic, architecture, AstraZeneca, Avastin, bachelor, Baxter, Bioscience, bladder, Boehringer, Boesgaard, bombardment, border, brain, built, cabinet, Cardinal, Carey, castration, CFO, chemoradiation, Chicago, CI, Cincinnati, civilian, classification, Cleveland, Clonality, Columbia, Copenhagen, Core, Cornell, Counsel, Covance, CPS, cut, cytokine, DC, Deacetylase, deal, deep, disaggregated, docetaxel, doctorate, Dohme, driven, Eisai, Erroneously, escalation, ESWI, explained, FDORA, featured, Flom, Gaza, GE, graduate, HDAC, hematologist, hematology, Hezbollah, Histone, Houthi, IC, identification, immunocytokine, indeterminate, INF, infectimune®, Ingelheim, Insulet, internship, Israel, Israeli, Ivey, Johnson, Kaposi, Kirk, lab, Lebanon, main, Meagher, Middle, naive, neutropenia, Nordisk, Novo, oncologist, Ontario, oversaw, Palestinian, panel, passage, pegged, Pennsylvania, pose, proportion, quantity, reconciling, reg, Regeneron, residency, residing, rocket, Roka, roundtable, salvage, Sarcoma, scientist, score, segment, session, Sharpe, Shepard, Shephard, Skadden, Slate, SOC, southern, spanning, spent, standing, Stereotactic, store, Strip, subset, succeeding, symptom, Takeda, tech, tenure, terrorist, thirteen, TRAE, unconfirmed, VEGF, veteran, Vice, weaker, West, Western, widening, Wilmington, Yemen
Removed:
Alter, Aspire, calculation, cDNA, CEO, Chapel, Cie, crystal, Eshelman, excellent, fellow, founder, functional, highlighted, Hill, Huang, impacting, injectable, Jumpstart, launching, Lauren, Leaf, lieu, Linkbase, meaningfully, mRNA, noncreditable, oncosec, opened, outbreak, pioneered, postdoctoral, quarantine, run, siRNA, spike, step, tablet, TB, vector, vested, withdrawing
Filing tables
Filing exhibits
Related press release
PDSB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement (No. 333-267041) on Form S-3 and registration statements (Nos. 333-275546, 333-267042, 333-264048, 333-261072, 333-234693, 333-231945, 333-231943, 333-229817, 333-223390, 333-223389, 333-216431, 333-216430, 333-210042, 333-210041, 333-207545) on Form S-8 of our report dated March 28, 2024, with respect to the consolidated financial statements of PDS Biotechnology Corporation.